Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Context Therapeutics Q2 EPS $(0.25)

Context Therapeutics Q2 EPS $(0.25)

Context Therapeutics (NASDAQ:CNTX) reported quarterly losses of $(0.25) per share.

byBenzinga Newsdesk

August 11, 2022

1 minute read

Context Therapeutics (NASDAQ:CNTX) reported quarterly losses of $(0.25) per share.

News

What In The World Is Going On With Datasea (DTSS) Stock?

By Henry Khederian

February 20, 3:43 PM

Datasea shares are trading lower by 15.9% during Tuesday's session. The company announced the establishment of a joint venture company in China.

DTSS

News

Easi-Set Worldwide Announces License Agreement With Canadian-Based Critical Precast Structures

By Benzinga Newsdesk

September 15, 9:18 AM

MIDLAND, VA / ACCESSWIRE / September 15, 2022 / Easi-Set Worldwide, a subsidiary of Smith-Midland Corporation (NASDAQ:SMID), today announced a signed license agreement with Critical Precast Structures Inc.

SMID

Casino Giant MGM Resorts Expects $100M Blow From Recent Cybersecurity Breach

By Shivani Kumaresan

October 6, 7:30 AM

MGM Resorts International (NYSE: MGM) disclosed in a regulatory filing on Thursday that the recent cybersecurity breach affecting its operations could have a negative impact on its third quarter 2023 results, predominantly in its Las Vegas operations, and a

MGM